Endophthalmitis caused by Enterococcus faecalis: Antibiotic selection and treatment outcomes

Ophthalmology

Volumn 110, Issue 8, 2003, Pages 1573-1577

  Scott, Ingrid U ^a   Loo, Roy H ^b   Flynn Jr , Harry W ^b   Miller, Darlene ^b  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CEFAZOLIN; CIPROFLOXACIN; DALFOPRISTIN PLUS QUINUPRISTIN; GENTAMICIN; LINEZOLID; VANCOMYCIN;

ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; CATARACT EXTRACTION; CLINICAL ARTICLE; CLINICAL FEATURE; DISEASE ASSOCIATION; DRUG CHOICE; ENDOPHTHALMITIS; ENTEROCOCCUS FAECALIS; EYE SURGERY; FEMALE; FOLLOW UP; HUMAN; MALE; MINIMUM INHIBITORY CONCENTRATION; PENETRATING KERATOPLASTY; PRIORITY JOURNAL; REVIEW; TRABECULECTOMY; TREATMENT OUTCOME; VISUAL ACUITY;

EID: 0042029453     PISSN: 01616420     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0161-6420(03)00502-5     Document Type: Article

References (29)

1. Joklik WK, Willett HP, Amos DB, eds. Zinser Microbiology, 19th. East Norwalk, CT: Appleton & Lange; 1988:463-75.
2. Bisno AL. Classification of streptococci. In: Mandell GL, Douglas RG Jr, Bennett JE, eds. Principles and Practice of Infectious Diseases, 3rd ed. New York: Churchill Livingstone; 1990:1518-9.
3. Ruoff KL, Garner CV. Streptococcal infections. In: Wentworth BB, ed. Diagnostic Procedures for Bacterial Infections, 7th ed. Washington, DC: American Public Health Association; 1987:491-9.
4. Choi S, Hahn TW, Osterhout G, O'Brien TP. Comparative intravitreal antibiotic therapy for experimental Enterococcus faecalis endophthalmitis. Arch Ophthalmol 1996;114:61-5.
5. Jones RN. Enterococcus. In: Schlossberg D, ed. Current Therapy of Infectious Disease. 2nd ed. St. Louis: Mosby; 2001:496-9.
6. Han DP, Wisniewski SR, Wilson LA, et al. Spectrum and susceptibilities of microbiologic isolates in the Endophthalmitis Vitrectomy Study. Am J Ophthalmol 1996;122:1-17.
7. Bailey IL, Lovie JE. New design principles for visual acuity letter charts. Am J Optom Physiol Opt 1976;53:740-5.
8. Scott IU, Schein OD, West S, et al. Functional status and quality of life measurement among ophthalmic patients. Arch Ophthalmol 1994;112:329-35.
9. Scott IU, Smiddy WE, Merikansky A, et al. Vitreoretinal surgery outcomes. Impact on bilateral visual function. Ophthalmology 1997;104:1041-8.
10. Scott IU, Smiddy WE, Feuer W, et al. Vitreoretinal surgery outcomes: results of a patient satisfaction/functional status survey. Ophthalmology 1998;105:795-803.
11. Traub WH, Geipel U, Leonhard B. Antibiotic susceptibility testing (agar disk diffusion and agar dilution) of clinical isolates of Enterococcus faecalis and E. faecium: comparison of Mueller-Hinton, Iso-Sensitest, and Wilkins-Chalgren agar media. Chemotherapy 1998;44:217-29.
12. Horvat RT, Potter LM, Bartholomew WR. Clonal dissemination of vancomycin-resistant Enterococci and comparison of susceptibility testing methods. Diagn Microbiol Infect Dis 1998;30:235-41.
13. Results of the Endophthalmitis Vitrectomy Study. A randomized trial of immediate vitrectomy and of intravenous antibiotics for the treatment of postoperative bacterial endophthalmitis. Endophthalmitis Vitrectomy Study Group. Arch Ophthalmol 1995;113:1479-96.
14. Brod RD, Flynn HW Jr. Endophthalmitis. In: Schlossberg D, ed. Current Therapy of Infectious Disease, 2nd ed. St. Louis: Mosby; 2001:45-50.
15. Kapusnik-Uner JE, Sande MA, Sande MA, Chambers HF. Antimicrobial agents: tetracyclines, chloramphenicol, erythromycin, and miscellaneous antibacterial agents. In: Hardman JG, Limbird LE, eds. Goodman & Gilman's The Pharmacological Basis of Therapeutics, 9th ed. New York: McGraw-Hill; 1996:1123-54.
16. Mandell GL, Petri WA Jr. Antimicrobial agents: penicillins, cephalosporins, and other beta-lactam antibiotics. In: Hardman JG, Limbird LE, eds. Goodman & Gilman's The Pharmacological Basis of Therapeutics, 9th ed. New York: McGraw-Hill; 1996:1073-102.
17. Chambers HF, Sande MA. Antimicrobial agents: the aminoglycosides. In: Hardman JG, Limbird LE, eds. Goodman & Gilman's The Pharmacological Basis of Therapeutics, 9th ed. New York: McGraw-Hill; 1996:1103-22.
18. Mandell GL, Petri WA Jr. Antimicrobial agents: sulfonamides, trimethoprim-sulfamethoxazole, quinolones, and agents for urinary tract infections. In: Hardman JG, Limbird LE, eds. Goodman & Gilman's The Pharmacological Basis of Therapeutics, 9th ed. New York: McGraw-Hill; 1996:1057-72.
19. Antony SJ, Diaz-Vasquez E, Stratton C. Clinical experience with linezolid in the treatment of resistant gram-positive infections. J Natl Med Assoc 2001;93:386-91.
20. Manzella JP. Quinupristin-dalfopristin: a new antibiotic for severe gram-positive infections. Am Fam Physician 2001;64:1863-6.
21. Mao LK, Flynn HW Jr, Miller D, et al. Endophthalmitis caused by streptococcal species. Arch Ophthalmol 1992;110:798-801.
22. Microbiologic factors and visual outcome in the endophthalmitis vitrectomy study. Am J Ophthalmol 1996;122:830-46.
23. Korzeniowski OM, Chowdhury MH. Endocarditis of natural and prosthetic valves: treatment and prophylaxis. In: Schlossberg D, ed. Current Therapy of Infectious Disease, 2nd ed. St. Louis: Mosby; 2001:122-8.
24. Eliopoulos GM, Moellering RC. Antimicrobial combinations. In: Lorian V, ed. Antibiotics in Laboratory Medicine, 3rd ed. Baltimore: Williams & Wilkins; 1991:432-92.
25. Roth DB, Flynn HW Jr. Antibiotic selection in the treatment of endophthalmitis: the significance of drug combinations and synergy [review]. Surv Ophthalmol 1997;41:395-401.
26. Kwok AK, Hui M, Pang CP, et al. An in vitro study of ceftazidime and vancomycin concentrations in various fluid media: implications for use in treating endophthalmitis. Invest Ophthalmol Vis Sci 2002;43:1182-8.
27. Cetinkaya Y, Falk P, Mayhall CG. Vancomycin-resistant enterococci. Clin Microbiol Rev 2000;13:686-707.
28. Edmond MB, Ober JF, Dawson D, et al. Vancomycin-resistant enterococcal bacteremia. Natural history and attributable mortality. Clin Infect Dis 1996;23:1234-9.
29. McGeer AJ, Low DE. Vancomycin-resistant enterococci. Semin Respir Infect 2000;15:314-26.